HomeEXECUTIVESMedin Technologies, Inc. Announces Appointment of Bob Baker as CEO

Medin Technologies, Inc. Announces Appointment of Bob Baker as CEO

Medin Technologies, Inc. a leading orthopedic industry contract manufacturer, announced that Bob Baker has joined the company as Chief Executive Officer and a member of its board of directors.

Bob Baker joins Medin with an accomplished background in strategic, commercial and operational leadership in the orthopedic industry, having most recently served as Chief Executive Officer of Glebar Company, a leading manufacturer of advanced grinding machine systems for the medical device industry and other end markets. In his tenure at Glebar, Bob led a strategic transformation of the business, restructuring the company to address new market challenges, upgrading operations, and completing several strategic add-on acquisitions.

“I am honored to be joining Medin at such a pivotal moment for the orthopedic industry,” said Bob. “Demand for quality orthopedic products continues to increase as the market begins to address the backlog of elective procedures created by the global pandemic. Medin and AMT are well positioned to meet this global demand through optimized production and product diversification. This is an incredible opportunity and I look forward to working with this great team through the combined companies’ next phase of growth.”

“We are thrilled and excited to have Bob join the team as CEO for Medin and AMT,” said Mark Kammert, Partner of Seven Point Partners, LLC. “Bob has a proven track record in demonstrating outstanding leadership qualities and delivering exceptional value to customers. As Medin and AMT’s growth continues to accelerate in the post-COVID environment, we are confident that Bob is the right leader to expand market opportunity in medical contract manufacturing, while at the same time building on the company’s strong reputation for world class quality, product design, and customer responsiveness.”

Seven Point Partners LLC owns Medin Technologies and its sister company, AMT Medical, Inc.

“OEM customers in the medical device and orthopedic implant sector have necessarily high expectations in terms of quality, design and product delivery,” said Seven Point Managing Partner Tom Burchill. “Bob’s strong track record of commercial and operational excellence in the medical products industry is ideal to meet this need while simultaneously driving long-term revenue growth, profitability and outstanding outcomes for our valued customers.”

Prior to joining Glebar, Bob was Vice President, Operations at Stryker Corporation, in support of the Orthopedics Group. Previously, he was a Captain in the U.S. Army, serving in Iraq and Afghanistan.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy